New Biomarker for Immune Checkpoint Inhibitors Identified in Human Lethal Cancers
by Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of many lethal cancers. However, only a small percentage of patients benefit from this therapy. Therefore, it …